National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA)
National Institutes of Health
Description
The CEBRA grant funds groundbreaking addiction research projects that are considered high-risk but have the potential for significant impact. These projects should explore new techniques or ideas not currently covered by NIDA, aiming to transform current understanding in the field.
The CEBRA supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA's current portfolio. The proposed research should develop or adapt revolutionary techniques or methods for addiction research or test innovative hypotheses that could transform curr…
Source
Grant ID
PAR-25-101
Agency
National Institutes of Health
Subcategory/Subagency
National Institute on Drug Abuse
Key Dates
Opportunity Released
December 30, 2024
Eligibility
The following categories of applicants are invited to apply:
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Eligible Agencies of the Federal Government
- U.S. Territory or Possession
- Public/State Controlled Institutions of Higher Education
- Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Small Businesses
- For-Profit Organizations (Other than Small Businesses)
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Local Governments (General)
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Private Institutions of Higher Education
- Non-domestic (non-U.S.) components of U.S. organizations
- Faith-based or Community-based Organizations
- Regional Organizations
- Non-domestic (non-U.S.) Entities (Foreign Organizations)
Awards & Funding
Total Funding
$150,000
Award Ceiling
$150,000
Funding Amount
~$150,000
Similar opportunities
- Avant Garde/Avenir award for Investigators conducting high risk/high reward research on HIV and Substance Use (or Substance Use Disorders)
Department of Health and Human Services
- D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
National Institutes of Health
- Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)
Department of Health and Human Services
- D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
National Institutes of Health
- Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
National Institutes of Health